Japan has pioneered regenerative medicine regulation with its Act on the Safety of Regenerative Medicine, yet access to clinical stem cell therapy remains limited to approved facilities with significant cost barriers. For Japanese patients seeking mesenchymal stem cell treatment for chronic conditions or tissue repair, our Chiang Mai clinic offers quality-controlled MSC protocols approximately six hours from Tokyo or Osaka, with Japanese-speaking clinical support and structured coordination with your Japanese physician.
Mesenchymal stem cell (MSC) therapy uses laboratory-expanded stem cells to target tissue damage, reduce chronic inflammation, and promote cellular repair. Cells are quality-tested and delivered under imaging guidance to ensure precise targeting of affected areas. The treatment process involves initial assessment, cell preparation by our laboratory team, and image-guided delivery to the treatment site. For a comprehensive understanding of the science, evidence, and treatment process, visit our full Stem Cell Therapy page.
Japanese patients value the quality-controlled MSC protocols, the structured clinical governance, and the significant cost difference compared to the limited domestic options available. Each stem cell programme is individually designed based on diagnostic assessment and treatment goals rather than a one-size-fits-all approach. Japanese-speaking clinical staff ensure that patients fully understand the treatment process, expected outcomes, and follow-up requirements. Comprehensive treatment records are provided for your Japanese physician to support ongoing care.
Yes. Thailand has a regulatory framework that permits stem cell therapy under proper medical supervision and quality standards.
Typically five to seven days in Chiang Mai.
Yes. Many Japanese patients combine stem cell therapy with anti-ageing or exosome protocols.
Structured video consultations at scheduled intervals after returning to Japan.
Treatment in Thailand is significantly more affordable than stem cell therapy at private Japanese clinics.
Yes. Comprehensive treatment summaries are provided for your local physician.
The Act on the Safety of Regenerative Medicine (再生医療等安全性確保法) requires institutional approval for stem cell treatments in Japan. This process is lengthy and limits the number of clinics that can offer these therapies, while also contributing to very high treatment costs at approved centres.
Most regenerative stem cell therapies are not covered by National Health Insurance in Japan. They are classified as advanced medical treatment (先進医療) with very limited coverage, meaning patients pay the full cost out of pocket at private clinics.
Yes. Flights from Osaka Kansai (KIX) to Chiang Mai operate regularly with a travel time of approximately 6 hours. Our Japanese-speaking coordinator can help arrange flights and transfers.